
|Articles|January 6, 2010
Novartis announces option exercise and merger proposal
Novartis is to exercise its option to purchase the remaining shares in Alcon, Inc., owned by Nestle S.A. at a weighted average price of US$180 per share in cash following the agreement between Nestle and Novartis in April 2008.
Advertisement
Newsletter
Advertisement
Latest CME
Advertisement
Advertisement















































